THE Senate Community Affairs
Committee has launched a probe
into the Therapeutic Goods
Administration’s regulatory
standards for the approval of
medical devices in Australia.
The committee will pay particular
attention to devices with high
revision rates, as well as the cost
effectiveness of subsidised devices,
the accuracy of the billing code,
and processes in place to ensure
products continue to meet
Australian standards.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.